Cardiosphere-derived cells (CDCs) confer cardioprotection in acute myocardial infarction by distinctive macrophage (Mϕ) polarization. Here we demonstrate that CDC-secreted exosomes (CDC exo ) recapitulate the cardioprotective effects of CDC therapy known as cellular postconditioning.
A cute myocardial infarction (MI) elicits a robust innate immune response that mobilizes a large population of neutrophils and macrophages (Mϕ) to the myocardium. This response, which plays out over the first few days after injury, occurs in a phasic manner whereby a rapid infiltration of neutrophils is succeeded by a heterogeneous influx of monocytes/ Mϕs. 1 The secondary phase of monocyte/Mϕ infiltration, which is implicated in the clearance of necrotic cellular debris, deposition of matrix, and maturation of scar tissue, critically determines ultimate infarct size (IS). Depletion of circulating monocytes/Mϕ 2 or selective depletion of M2-like healing Mϕ 3 exacerbates tissue injury and impairs cardiac function after MI. Although Mϕ heterogeneity exists within the myocardium at steady state 4 and after MI, 5 it is unclear which environmental cues confer the distinct polarization profile(s) observed in vivo. 6 Cardiosphere-derived cell (CDC) therapy has been utilized as a strategy to treat ischemic heart disease in both small and large animals, as well as in humans. Despite limited retention within the host myocardial tissue after intracoronary or direct myocardial injection, 7 the beneficial effects of cell therapy are long-lasting. 8 Our laboratory has recently demonstrated that exosomes (nanosized lipid bilayer vesicles; ≈30-150nm) are a potent secretory component of CDC therapy after MI, 9 as confirmed by Barile et al. 10 These vesicles are secreted by many cell types throughout the body for local or remote cell-to-cell communication; they contain a specific payload of small RNAs (eg, miRNA, snoRNA, Y RNA, etc) 11 and protein (eg, transcription factors, transmembrane receptors, integrins, etc), 12 and are readily taken up by numerous cell types, including Mϕs, 13 fibroblasts, 14 and endothelial cells. 15 Here, we extend our recent work on cellular postconditioning by CDCs [16] [17] [18] by identifying CDC exosomes (CDC exo ) 19 as key elements of the cellular secretome that confer cardioprotection in MI. We further demonstrate that miR-181b within CDC exo is a critical mediator of Mϕ polarization in vitro and cardioprotection in vivo.
METHODS Experimental Protocol, Animals, and Surgical Procedures
All studies were performed at Cedars-Sinai Medical Center in accordance with the Institutional Animal Care and Use Committee guidelines.
Rat
In vivo experimental protocols were performed on 7-to 10-week-old female Wistar-Kyoto rats (Charles River Labs). To induce ischemia/reperfusion (IR) injury, rats were provided general anesthesia, and then a thoracotomy was performed at the 4th intercostal space to expose the heart and left anterior descending coronary artery. A 7-0 silk suture was then used to ligate the left anterior descending coronary artery, which was subsequently removed after 45 minutes to allow for reperfusion. Twenty minutes later, cells (5x10 5 ; in 100 μl PBS) or exosomes (35 μg, 105 μg, or 350 μg; in 100 μL PBS) were injected into the left ventricular cavity with an aortic cross-clamp over a period of 20 seconds.
Pig
In vivo experimental protocols were performed on adult female Yucatan mini-pigs. To induce IR injury, pigs were provided general anesthesia, and then an angioplasty balloon was threaded into the mid-left anterior coronary artery just after the first diagonal branch and inflated for 90 minutes. Thirty minutes after reperfusion, animals were allocated to receive CDC exo (7.5 mg) or placebo (Iscove's Modified Dulbecco's Medium). To rule out any complications with retention of CDC exo , we performed a direct intramyocardial injection for delivery. This procedure was performed in an open-chest model (median sternotomy) using a 25 G needle. The infarcted area was identified (grey and stiff zone), and 10 sequential injections (0.75 mg) were administered at the perimeter of the infarct (border zone).
Cardiac Function Measurements

Rat
Transthoracic echocardiography (Vevo770, VisualSonics) was performed on rats at baseline (preischemia) and before euthanization (48 hours or 2 weeks). Two-dimensional short and long axes were visualized. Three representative cycles were captured for each animal/time point, and measurements for left ventricular (LV) end-systolic dimension, LV
Clinical Perspective
What Is New?
• Here we discover that exosomes mediate the cardioprotective effects of cardiosphere-derived cells (CDCs) administered after reperfusion in rats with acute myocardial infarction.
• Treatment with either CDCs or their secreted exosomes reduces infarct size and improves functional recovery.
• A specific microRNA species within CDC-derived exosomes, acting on macrophages, is implicated as a key mediator of the cardioprotective benefits.
What Are the Clinical Implications?
• Allogeneic CDCs are already in advanced clinical testing when administered months after myocardial infarction (ALLSTAR trial; URL: ClinicalTrials. gov; Unique Identifier: NCT01458405).
• The present findings give new reason to test the idea that allogeneic CDCs may be efficacious in preventing scar formation and improving cardiac function when given in the early reperfusion period adjunctive to percutaneous coronary intervention.
end-diastolic dimension, and fractional area of change were obtained and averaged.
Pig
To measure LV function, left ventriculograms were performed before infusion (after MI) and before euthanization (48 hours) using a pigtail catheter inserted into the LV. Two incidences were studied: a 45º left anterior oblique projection and a 30º right anterior oblique projection 20º cranial projection. LV ejection fraction was determined by averaging those 2 measurements.
IS Evaluation
Rat
Two days after IR injury, hearts were arrested in diastole after intraventricular injection of 10% KCl. Hearts were then excised, washed in PBS, and cut into serial sections of ≈1 mm in thickness (from apex to basal edge of infarction). Sections were incubated with 2,3,5-Triphenyl-2H-tetrazolium chloride (TTC, 1% solution in PBS) for 20 minutes in the dark, washed with PBS, and then imaged and weighed. Infarcts were delineated from viable tissue (white versus red, respectively) and analyzed using ImageJ software as previously reported. 16 Infarct mass, viable mass, and LV mass were calculated by extrapolating for infarct and noninfarct volumes (based on the areas calculated from both sides of a tissue section) and weight of the tissue. Percentage infarct mass was calculated using (Infarct Mass/Viable Mass) ×100%.
Pig
Two days after infusion, animals underwent lateral thoracotomy. A catheter was inserted into the left appendage, and Thioflavin T (50 mL, 2%) was injected into the left atrium to assess microvascular obstruction. Then an angioplasty balloon was inflated at the same position used for the infarct, and Gentian violet (50 mL, 1.8%) was injected to assess area at risk (AAR). Animals were then euthanized, and the hearts were explanted and sectioned into 1 cm slices. TTC staining was performed to determine IS. IS, microvascular obstruction, and AAR were then determined as previously described. 17 AAR was reported as a percentage of the total LV mass, and both IS and microvascular obstruction were reported as a percentage of the AAR.
17
In Vitro Cell Culture
Bone Marrow-Derived Mϕ
Bone marrow was isolated as described. 16 Briefly, bones from rat (femur) or pig (rib) were sterilized with ethanol (70% in H 2 O), flushed with PBS (containing 1% FBS, 2 mM ethylenediaminetetraacetic acid), and filtered through a 70 μm filter. Red blood cells were lysed with ACK buffer (Invitrogen) and resuspended in Iscove's Modified Dulbecco's Medium (containing 10% FBS, 10 ng/mL macrophage colony-stimulating factor). The resulting cell suspension was plated and grown for 7 days to obtain Mϕ. Polarization of Mϕ toward M1 (100 ng/mL LPS and 50 ng/mL interferon γ; Sigma-Aldrich and R&D Systems, respectively), M2 (10 ng/mL interleukin-4 and interleukin-13; R&D Systems), or M CDCexo (105 μg) was performed on the night between days 7 and 8 (≈18 hours).
Cardiac Mϕ
Hearts were collected and processed to isolate cardiac Mϕ after ischemic injury as previously described. 16 Briefly, 2 days after MI, hearts from animals treated with fibroblast exosomes (Fb exo ) or CDC exo were perfused with PBS and collected. Cardiac tissue was minced and digested, and the resulting suspension was filtered (70 μm) to generate a single-cell suspension. Mononuclear cells were separated by centrifugation using a density gradient (Histopaque-1083; Sigma) and then resuspended in Roswell Park Memorial Institute media (supplemented with 1% FBS) and plated (37°C, 5% CO 2 ). Two hours later, cardiac Mϕ were washed with PBS and used for downstream analyses.
Neonatal Rat Ventricular Myocytes
Cells were isolated and cultured as described. 16 
Human Umbilical Vein Endothelial Cells
Cells were purchased (ATCC) and cultured according to the distributor's recommendations.
Statistics for Nongenomic Data
Results are expressed as mean±SEM. Linear regression analysis was performed to test the linear relationship between groups. Each replicate value was considered as an individual point to determine R 2 . To determine differences between groups at a single time point, data were tested using either 2-tailed, unpaired, Student's t test or 1-way analysis of variance followed by Tukey's multiple comparisons test (outliers were excluded if Z score was >3 or <-3). To determine differences between groups at different time points/conditions, data were tested using repeated measures analysis of variance followed by Sidak's multiple hypothesis correction, 2-way analysis of variance followed by Holm-Sidak's multiple hypothesis correction, or multiple t tests followed by HolmSidak's multiple hypothesis correction (as denoted within the figure legends). To test for linear trend, we performed a 1-way analysis of variance followed by a posttest for linear trend. All analyses were performed using Prism 5 software (GraphPad), and only differences with a P<0.05 were considered statistically significant.
Refer to the online-only Data Supplement for additional materials and methods.
RESULTS
Characterization of CDC Exosomes
CDC exosomes (CDC exo ) were isolated from serumfree media conditioned by human CDCs for 5 or 15 days in culture ( Figure IA in the Data Supplement). The conditioned media were then collected or concentrated by ultrafiltration by centrifugation (UFC, Millipore) to assess particle number and size (Nanoparticle Tracking Analysis, Malvern Nanosight), as well as protein concentration and protein marker expression (Figure 1 and Figure IB in the onlineonly Data Supplement). The relationship between particle number and protein content was linear in ORIGINAL RESEARCH ARTICLE CDC exo from each of 2 distinct human lines ( Figure  1C ). Concentration of exosomes by UFC reduced the suspension volume (>10-fold; Figure 1A ) without a measurable loss of particles ( Figure ID in the online-only Data Supplement). Human dermal Fb exo (shown to be functionally inert in vivo 9 ) served as a negative control and were isolated and characterized in parallel under equivalent conditions ( Figure  IC in the online-only Data Supplement). The mode particle size for CDC exo was ≈150 nm in diameter, expressing typical exosome markers (including CD63, Alix, and HSP70), as well as the CDC surface marker CD105. Although this size distribution biases higher than what is generally quoted for exosomes on the basis of desiccation-prepared electron microscopy (30-100 nm), 20 the observed range is typical of hydrated exosomes measured by dynamic light scattering or nanoparticle tracking analysis. 20 For uniformity, given the elevated particle number, we performed all subsequent experiments using CDC exo isolated from 15-day conditioned media.
CDC exo Administered After Reperfusion in a Rat Model of Acute MI Mimic the Cardioprotective Effects of CDCs
To examine whether CDC exo could recapitulate the cardioprotective effects observed with CDCs, we delivered CDC exo in vivo. First, we demonstrated that CDC exo were retained within the heart by prelabeling CDC exo with DiI (Invitrogen), performing a modified version of our in vivo protocol ( Figure 2A ) by sacrificing rats after 2 hours of reperfusion, and examining exosome distribution by fluorescence imaging (Xenogen; Figure IIA 220 CDC exo ). B, Representative protein immunoblots of exosome (CD63, CD81, Alix, HSP70, and MHCII) and CDC (CD105) markers in human CDC exosomes. C, Correlation between particle number and protein amount in serially diluted samples of exosomes. Graphs depict mean ± SEM. Supplement). Forty-eight hours later, animals were euthanized and hearts excised for IS determination by TTC staining. Confirming our earlier report, 16 rCDCs (5x10 5 cells) reduced IS. Pretreatment of rCDCs with GW4869 abrogated the cardioprotective efficacy of rCDCs, consistent with the idea that exosome secretion is required for rCDC bioactivity. We further tested this idea by applying human CDC exo directly in lieu of cells. CDC exo reduced IS to a similar level as rCDCs at doses of 350 μg and 105 μg but not at 35 μg ( Figure 2B and Figure IIC in the online-only Data Supplement). Based on these data, we proceeded to test the potency of CDC exo versus inert Fb exo . 9, 11 Third, utilizing 350 μg protein as our standard dose, we show that CDC exo from 2 human CDC lines (220 and 155) reduced IS to a similar level as rCDCs, in contrast to Fb exo and PBS controls ( Figure 2C and 2D). These data were further validated with 3 additional human CDC exo lines ( Figure IID 
16,18
Intramyocardial Injection of CDC exo Administered After Reperfusion in a Pig Model of AMI Mimics the Cardioprotective Effects of CDCs
To confirm these findings, we validated our work in the porcine model ( Figure 3A) . Briefly, Yucatan mini- CDC exo ) or fibroblasts (Fb exo ; 350 μg). D, Quantification of infarct mass in hearts from groups defined in C (n=5/group, mean ± SEM). Statistical significance was determined using 1-way analysis of variance followed by Tukey's multiple corrections test. *P<0.05 versus PBS and Fb exo , respectively.
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pigs underwent 90 minutes of ischemia followed by 30 minutes of reperfusion before direct open-chest intramyocardial injection of CDC exo (7.5 mg) or placebo. Cardiac function was assessed at 48 hours, with subsequent euthanasia and IS determination by TTC. After treatment with CDC exo , LV ejection fraction was better preserved ( Figure 3B ; Figure IVA and IVB in the online-only Data Supplement), microvascular occlusion (microvascular obstruction/AAR) was reduced, and IS (IS/AAR) was attenuated relative to placebo ( Figure 3C and 3D). Furthermore, we noted a reduction in CD68+ Mϕ infiltration into the infarct of CDC exo -treated versus placebo animals ( Figure 3E and 3F). Together these in vivo porcine data support the hypothesis that CDC exo are key mediators of CDC-induced cardioprotection, not only in rodents but also in a clinically relevant largeanimal model.
Implication of Uniquely Polarized Mϕ as Effectors of Cardioprotection
The first evidence that inflammation might be involved in cellular postconditioning came from our initial studies in rats, 16 where we found that CDCs modulate Mϕ Figure 4F ) as described. 16 Expression of proinflammatory genes Nos2 and Tnf was significantly attenuated in cardiac Mϕ isolated from CDC exo -treated animals ( Figure 4G ).
In vitro, rat bone marrow-derived Mϕ exposed to CDC exo ( Figure 5A ) exhibit a distinctive shift in Mϕ polarization (not observed with Fb exo ), including elevation in anti-inflammatory gene expression levels of Arg1, Il4ra, Tgfb1, and Vegfa without any significant change in Tnf ( Figure 5B ). These effects occur dose-dependently ( Figure 5C and Table I Figure 5D and 5E, Figure VIB in the online-only Data Supplement), again recapitulating the effects of CDCs. 16 Together these data support the notion that CDC exo are crucial in mediating the Mϕ responses underlying cellular postconditioning.
16
CDC exo Have a Distinct miRNA Signature
Exosomes are intriguing as signaling intermediates with cargo rich in small RNA molecules. 11, 12 The composition of exosomes is not determined randomly but rather uniquely regulated by cell source and environmental stressors. 21 To understand how CDC exo confer Mϕ polarization, we performed total RNA-sequencing (RNA-seq) on exosomes isolated from CDCs (CDC exo ) and Fbs (Fb exo ) and then aligned them to a database of both short and long RNA annotations. To identify the most biologically relevant changes, we performed 1 set of biological replicates using the Illumina RNAseq platform and a second using the Ion Torrent platform ( Figure 6 ). 22, 23 Globally, the number of reads (and thus the RNA content) mapping to different classes of RNAs were similar between CDC exo and Fb exo ; the greatest number of reads mapped to protein coding genes (RefSeq) and tRNAs, whereas fewer reads mapped to short RNAs (eg, miRNAs and piRNAs; even fewer mapped to scaRNAs and snoRNAs) ( Figure VII in the online-only Data Supplement). However, the largest and most consistent proportional change was observed in Graphs depict mean ± SEM with n=3 to 5/group. Statistical significance was determined using 2-way analysis of variance followed by Holm-Sidak's multiple corrections test, 1-way analysis of variance followed by Tukey's multiple corrections test, or multiple ttests followed by Holm-Sidak's multiple corrections test. *P<0.05. D) . D, The 7 miRNAs with the most significant downregulation of predicted targets in CDC exo -polarized Mϕ, ordered by significance. Top, Fold-change for all predicted miRNA gene targets. Bottom, Statistical significance (hypergeometric test; see Methods in the online-only Data Supplement) of the association between predicted miRNA targets and downregulated genes (-log 10 P-values); annotations at the bottom: miRNAs with overexpression in CDC exo compared with Fb exo , from C. E, Comparison of untreated Mϕ (rn-control) and CDC exoprimed Mϕ (rn-M CDCexo ) gene expression to published datasets. 25, 26 Only genes with homology between rat (rn), human, and mouse (mm) are shown, whereas those with undetectably low expression in all our Mϕ samples are filtered out. Genes are sorted by differential expression in rn-M CDCexo , from the most downregulated (Left, blue) to the most upregulated (Right, red).
Gene expression values are shown as relative (log-transformed) fold change relative to other samples in the same study. F, Venn diagrams highlight the highly significant associations between genes sets of rn-M CDCexo to published miR-181a/b knockout (KO) (miR-181 KO) thymocytes 27 ; significance values were calculated using a hypergeometric test (see Methods in the online-only Data Supplement). Downregulated genes in our model (+CDC exo ) were associated with genes upregulated in miR-181 KO thymocytes (Upper Left, P=2.6x10 ). These findings were not true for genes regulated in the same direction (Upper Right and Lower Left). G, Predicted miR-181 target genes from miRecords are shown in the same order as E and are concentrated in those genes downregulated rn-M CDCexo and upregulated miR-181 KO thymocytes. H, Venn diagrams show the strong association of predicted miR-181 targets and those genes downregulated in rn-M CDCexo (P=1.3x10 -21 ). Significance values were calculated using a hypergeometric test (see Methods in the online-only Data Supplement). Refer to the Methods in the online-only Data Supplement for sample size and additional methods.
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the miRNA class, where CDC exo produced 5-and 8-fold greater reads than Fb exo in the Illumina and Ion Torrent libraries, respectively ( Figure 6A and 6B) . Next, we focused on the reads that aligned to miRNA annotations and normalized both sets of libraries using DESeq 2 to identify the miRNAs with consistent changes in expression between CDC exo and Fb exo ( Figure 6C ). Although the 2 platforms (Illumina and Ion Torrent) had technical differences (Pearson correlation coefficient ≈0.6), several miRNAs stood out as having significant differential expression. The miRNAs that were uniquely enriched in Fb exo included miR-199, miR-3676, and miR-3648, whereas those uniquely enriched in CDC exo included miR-126 and miR-181b; in addition, miR-181a was enriched just below the threshold of significance in CDC exo . Interestingly, miR-181a/b stood out as having large numbers of differentially expressed target genes in CDC exo -treated Mϕ (marked as red in Figure 6C and described in detail below).
miR-181 as a Candidate Effector of CDC exo -Mediated Mϕ Polarization
To investigate the effect of CDC exo miRNAs on Mϕ, we performed RNA-seq on 2 biological replicates of unprimed (control) or CDC exo -primed (CDC exo ) rat bone marrow-derived Mϕ. Then we used gene annotations from the NextBio functional annotation database (Illumina Inc.) 24 to investigate the functions of genes with altered expression after exposure to CDC exo . Specifically, we compared differentially regulated genes to predicted miRNA targets from the miRecords database (reverse pathway analysis 25, 26 ) and found that target genes for several miRNAs enriched in CDC exo were predominantly downregulated in CDC exo -treated Mϕ ( Figure 6D ). This downregulation of miRNA target genes was not observed for randomly permuted gene sets of the same size ( Figure VIIIA in the online-only Data Supplement). The fact that miRNAs with proportionally higher expression in Fb exo (eg, miR-30 and let-7) were also downregulated in CDC exo -primed Mϕ may reflect the higher absolute levels of these miRNAs in CDC exo ( Figure 6A ). Consistent with this interpretation, we found a significant downregulation of predicted targets for all highly expressed miRNAs examined, whether they had proportionally higher expression in CDC exo or Fb exo ( Figure VIIIB in the online-only Data Supplement). However, the 3 most significant miRNAs (miR-181, miR-27, and miR-19) were all proportionally higher in CDC exo and thus represented strong candidates for conferring the functional changes observed in Mϕ ( Figure 6D ). miR-181 also had >10-fold higher proportional abundance in CDC exo versus Fb exo ( Figure 6C ), compared with miR-19 and miR-27 (both had <2-fold higher abundance). These data pointed to the miR-181 family as a strong candidate for the key regulatory cargo contained in CDC exo .
To further explore transcriptional changes in CDC exotreated Mϕ, we performed an unbiased comparison of our RNA-seq dataset with 2 published rodent immune cell RNA-seq datasets ( Figure 6E ). First, we compared expression changes in our CDC exo -treated cells to a mouse Mϕ RNA-seq dataset. 23 This comparison revealed a similar pattern of gene expression changes, with our unprimed rat Mϕ resembling the mouse M0 state and our CDC exo -primed rat Mϕ resembling the mouse M2 state ( Figure 6E ). Because complete concordance was not observed between the 2 datasets, these findings support the notion 16 that CDC exo -primed Mϕ are not ordinary M2 Mϕ but lie somewhere within (or outside) the M1-M2 spectrum. We next compared a mouse miR-181a/b knockout thymocyte dataset 22 with CDC exo -primed Mϕ (Figure 6E and 6F) . This particular perturbation came up as the most strongly related among thousands of gene perturbation datasets within the NextBio database, and our results demonstrated a strong degree of concordance ( Figure 6E ). Overlapping the genes with statistically significant expression changes across 2 replicates revealed that those downregulated in our model (+CDC exo ) were significantly associated (P=2.6x10 ). Further, when grouped based on their Gene Ontology annotation, these genes clustered in biological processes associated with increased translation, metabolism, and oxidative phosphorylation (Table II in the online-only Data Supplement). Genes downregulated in our model had no statistical association with genes downregulated in miR-181a/b knockout thymocytes ( Figure 6F , Lower Left), nor did the converse ( Figure 6F , Upper Right). This association is even stronger than the association with predicted miR-181 targets (P=1.3x10 -21 ; Figure 6G and 6H), further supporting the notion that miR-181 may be a critical factor regulating CDC exo function and by far the most promising single candidate mediator of the transcriptomic changes observed in CDC exo -primed Mϕ.
miR-181b in Exosomes Confers Cardioprotection
The miR-181 family comprises 4 known members (miR181a, miR-181b, miR-181c, and miR-181d), which have been implicated as modulators of myeloid leukemia and stem cell differentiation. 27 To better understand the functional effects of miR-181, we assessed the gene expression pattern of miR-181 family members in CDCs and CDC exo ( Figure 7A ; miR-181c and miR-181d were undetectable by quantitative polymerase chain reaction and thus not presented). Levels of miR-181a but not miR-181b were higher in human CDCs relative to Fbs ( Figure 7A ). In contrast, CDC exo were highly enriched for miR-181b but not miR-181a, indicative of highly se-lective transfer of miRNA cargo into CDC exo ( Figure 7A and Figure IXA in the online-only Data Supplement), as seen with other miRNAs in other cell types. 28 The expression levels of miR-181a and miR-181b differed in various isolated cardiac cell types (eg, cardiomyocytes, endothelial cells, Mϕ; Figure IXB in the online-only Data Supplement) and were not changed within the hearts of untreated animals before or after ischemic injury ( Figure 7C) .
We tested the effects of miR-181b on various cardiac cell types, including endothelial cells and Mϕ in vitro. Consistent with its known targets, 29 treatment with miR-181b but not miR-Scramble reduced transcript levels for E-selectin, VCAM-1, and ICAM-1 in endothelial cells ( Figure XA in the online-only Data Supplement). Interestingly, these effects were reproduced in a similar manner after CDC exo or Fb exo with miR-181b but not Fb exo treatment (Figure XB in the online-only Data Supplement). Next, we performed a scratch assay to examine whether miR-181b modulates endothelial migration. Although CDC exo enhanced scratch closure in vitro, miR-181b alone had no effect ( Figure XC and XD in the online-only Data Supplement).
To further validate the functional efficacy of exosomal miR-181b in vivo, we overexpressed miR-181b in Fb exo (naturally low in miR-181b) or antagonized miR-181b in CDC exo and measured IS in our rat model (Figure 2A) . Briefly, Fb exo were transfected with miR181b mimic (Fb exo(Mimic) ) ( Figure IXC in the online-only Data Supplement) and CDC exo were transfected with an Graphs depict mean ± SEM. Statistical significance was determined using 2-way analysis of variance followed by Holm-Sidak's multiple corrections tests or 1-way analysis of variance followed by Tukey's multiple corrections test. *P<0.05.
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antagomir to miR-181b (CDC exo(Antagomir) ); miR-scramble was used as a transfection control in both types of exosomes (Fb exo(Scramble) and CDC exo(Scramble) ). After 48 hours of reperfusion, Fb exo(Mimic) and CDC exo(Scramble) reduced IS and Mϕ infiltration, although not to the same extent as CDC exo relative to Fb exo , Fb exo(Scramble) , and CDC exo(Antagomir) ( Figure 7B , 7D, and 7E, Figure XI in the online-only Data Supplement). Thus, miR-181b reproduces the cardioprotective effects of CDC exo while blocking miR-181b blunts those effects.
miR-181b Inhibits the Expression of PKCδ (Protein Kinase C δ)
To better understand how miR-181b may lead to cardioprotection, we honed in on the target genes for miR-181b within CDC exo -treated Mϕ. Among known miR-181b targets, PKCδ (prkcd) was 1 of the most significantly downregulated (4.82x10 -30 ) ( Figure 7F ). Consistent with previous reports, 27 expression levels of prkcd were reduced in Mϕ transfected with miR181b compared with miR-scramble control ( Figure  8A ). PKCδ enhances inflammatory gene expression (eg, tumor necrosis factor α), 30 as well as cell differentiation, growth, and death, 31 and PKCδ inhibitors are known to induce or enhance cardioprotection. 32, 33 We thus hypothesized that PKCδ acts as a downstream effector of CDC exo -mediated cardioprotection by miR-181b-induced suppression of prkcd in Mϕ. To test this hypothesis, we transfected Mϕ with a specific small interfering RNA (siRNA), which effectively suppressed prkcd ( Figure 8B ). Given our previous demonstration that adoptive transfer of CDC-conditioned Mϕ mimicked cardioprotection by CDCs, we modified our rat model of IR (Figure 2A ) to adoptively transfer Mϕ transfected with either PKCδ siRNA (Mϕ (PKCδ siRNA) ) or scramble siRNA (Mϕ (scramble siRNA) ). Adoptive transfer of Mϕ (PKCδ siRNA) reduced IS ( Figure 8C and 8D) , mimicking the effects of CDC exo (Figures 2 and 7) . Thus, our data as well as published work are consistent with the hypothesis that PKCδ inhibition by miR-181b in CDC exo underlies the cardioprotection induced by CDCs ( Figure 8E ).
Despite the compelling evidence pinpointing PKCδ as a likely downstream effector, it is clear that exosomes and their miRNAs have protean effects, which may be synergistic; picking a single candidate may oversimplify the actual biology. Table III in the online-only Data Supplement lists other miR-181b targets implicated in Mϕ polarization and downregulated in CDC exo -primed Mϕ. Conversely, we observed upregulation (and downregulation in miR-181a/b knockout thymocytes; Figure 6F , Lower Right) in several genes associated with Mϕ polarization, oxidative phosphorylation, and phagocytosis (Table IV in the online-only Data Supplement). Together these data point to a dramatic shift in Mϕ polarization by CDC exo that reduces proinflammatory signaling and enhances phagocytosis to promote a cardioprotective response in vivo.
DISCUSSION
Myocardial IR injury leads to necrosis and apoptosis of the underlying myocardium (myocytes, endothelial cells, etc). 34 The acute inflammatory response that follows IR injury is a physiologically archetypal sequence of events that begins with the mobilization and infiltration of neutrophils and follows with Mϕ influx. 35 Several Figures 1-3) ; ii, CDC exo , rich in miR181b, alter the polarization state of Mɸ ( Figures 4-6) ; iii, enrichment of miR-181b within exosomes recapitulates cardioprotection ( Figure 7) ; iv, downregulation of PKCδ in Mɸ by miR-181b is responsible, at least in part, for cardioprotective response of CDC exo (Figure 8 37 It is also becoming clearer that Mϕ heterogeneity (differences in polarization state in a spectrum typically defined by M1 and M2 states at the extremes 38 ) is a nuanced process that is highly dependent on microenvironmental cues (protein-dependent, 38 extracellular vesicles, 39 or pH/ion imbalance 40 ). Over the past decade, cell therapy has demonstrated some success in the treatment of ischemic disease despite limited cell retention. 41 Our group recently demonstrated in pigs 17 and rats 16 the existence of a novel cardioprotective process known as cellular postconditioning: CDCs delivered in ≤30 minutes of reperfusion dramatically reduce IS. Macrophages are required for cellular postconditioning and appear to work by adopting a unique highly phagocytic polarization state (non-M1, non-M2) in response to CDCs. 16 We have also shown that CDC exosomes (CDC exo ) increase viable mass, promote angiogenesis, and reduce scar size in established MI. 9, 14 Exosomes are intriguing paracrine signals that can shuttle payloads from cell to cell. 12 Not surprisingly, exosomes are extremely diverse in their contents and vary greatly among cell types. Their characteristic traits are reflected in their vesicular composition (lipid, protein, small RNA, etc), heterogeneity (totality of loaded and unloaded vesicles), and concentration (number of particles secreted) in vivo and in vitro, 21 which are further modulated in time and space by environmental cues. 42 Our lab 9, 14 and ≥2 others 10, 43 have demonstrated the bioactivity of exosomes derived from cardiac stem cell populations.
Here we demonstrate that CDC exo are a unique population of exosomes that have a distinct protein expression pattern (CD63, HSP70, and CD105) and miR profile (including high expression of miR-181b). In contrast to exosomes secreted by fibroblasts, CDC exo do not exacerbate tissue injury 44 ; instead, they confer cardioprotection when delivered after reperfusion by localizing to the ischemic tissue, reducing IS, reducing the total number of CD68+ Mϕ, and shifting the polarization state of Mϕ toward a distinct phenotype. Interestingly, CDC exo appear to specifically home to the site of injury within infarcted myocardium. Localization to this area of interest may confer a local restructuring of the microenvironment and polarize recruited monocytes/Mϕ toward a reparative phenotype. Although the mechanisms for CDC exo localization remain to be defined, homing signals, such as angiotensin II type I receptor (targets exosomes to cardiomyocytes, skeletal muscle, and mesenteric resistance arterioles), 45 may be responsible for exosome retention at the site of injury. Furthermore, CDC exo enhance the endogenous phagocytic capacity of Mϕ, a characteristic trait that may enhance clearance of necrotic cell debris and alleviate excessive proinflammatory stress within the infarcted heart 35 (a salutary process known as efferocytosis 46 ). This work further expands our understanding of how CDCs confer cardioprotection and Mϕ polarization. 16 By reverse pathway analysis on transcriptomic data from both CDC exo (cargo) and CDC exo -primed Mϕ (recipient), we were able to pinpoint 1 key RNA component through which CDC exo confer these functional benefits. Probing our own sequencing data against publicly available gene expression and miRNA target prediction databases, we identified miR-181b as our top candidate. This miRNA species displayed the highest relative abundance within CDC exo and the strongest correlation in its downregulation of target genes in CDC exo -primed Mϕ. miR-181b has been implicated in the attenuation of nuclear factor-κB signaling in endothelial cells 29, 47 and suppression of myeloid differentiation in acute myeloid leukemia, 27 consistent with our findings that CDC exo -primed Mϕ reduce proinflammatory gene expression and polarize Mϕ away from an M1 phenotype. Furthermore, the observed suppression of the miR-181b target PKCδ and concomitant increases in genes involved in translation and oxidative phosphorylation hint that CDC exo shift the metabolic profile of Mϕ 48 toward a cardioprotective phenotype. Adding a miR-181b mimic to otherwise inert Fb exo qualitatively reproduces CDC exo cardioprotection, whereas blocking miR-181b in CDC exo blunts cardioprotection. Although the evidence points to the functional efficacy of miR181b in reducing IS and Mϕ polarization, the lack of complete congruence with our CDC exo data are not surprising. CDC exo contain a multitude of small RNAs and proteins, not only miR-181b. Many of the other components undoubtedly are bioactive, exerting the overall functional benefits as an ensemble.
Our data provide compelling evidence for the role of CDC exo in polarizing Mϕ to a phenotype that improves the healing response after injury. Specifically, we demonstrate that miR-181b is a key component within CDC exo that confers cardioprotection by targeting PKCδ within Mϕ to induce a distinctive polarization state. These data add to the list of cardioprotective/cardioregenerative properties previously attributed to CDC exo (eg, antifibrotic effects, reduction of cardiomyocyte death and hypertrophy, myocardial regeneration, improved cardiac function, and angiogenesis). 9, 11, 14 Although we define miR-181b as 1 important component within CDC exo , the remaining composition (other noncoding RNAs, as well as proteins and lipids) of CDC exo requires further examination 49 to unravel the details of synthesis, release, homing, pathway regulation, and cellular uptake of CDC exo in vitro and in vivo. Likewise, although we have implicated PKCδ as 1 downstream contributor to CD-C exo -mediated cardioprotection, other plausible effectors remain to be investigated. Such redundancy would ORIGINAL RESEARCH ARTICLE be consistent with the notion that exosomes contain a plethora of bioactive molecules that can target multiple signaling pathways synergistically. 50 
